Planned Parenthood Sites and Grantees Withdrawing From Title X If Court Doesn’t Block New Regulations
Source Planned Parenthood Sites and Grantees Withdrawing from Title X Program If Court Does Not Block New Regulations
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →
Source Planned Parenthood Sites and Grantees Withdrawing from Title X Program If Court Does Not Block New Regulations
At 12:30 p.m. ET on Wednesday, April 21, KFF will hold a web briefing to highlight key findings on sexual and reproductive health from KFF’s national Women’s Health Survey. The presentation will be followed by a discussion with leaders in sexual and reproductive care about what those findings mean for policy and practice, how the pandemic has begun to reshape the provision of sexual and reproductive health care, and implications for the future of the…
On April 15th, the Department of Health and Human Services (HHS) published proposed regulations for the Title X federal family planning program to replace the Trump Administration’s rules, which prohibited abortion referrals and co-located abortion services. The Biden Administration proposes to largely re-instate the Title X regulations that were in place from 1993-2019, with new additions focusing on “ensuring access to equitable, affordable, client-centered, quality family planning services” for all clients. HHS is accepting public…
With the country waiting on the Supreme Court’s decision on Dobbs v. Jackson Women’s Health Organization, the case that could overturn Roe v. Wade, many are looking towards telehealth as an alternative to expand access to medication abortion. A new KFF issue brief explains the newly revised Food and Drug Administration (FDA) policy on medication abortion and the differential impact this could have on states by assessing the intersection of federal policy regarding dispensing medication…
This data note presents key data points describing the current state of the Medicaid program as it affects women.
On December 1, the Supreme Court will hear their first abortion case that could overturn Roe v. Wade, with a solid conservative majority. The case, Thomas E. Dobbs, State Health Officer of the Mississippi Department of Health v. Jackson Women’s Health Organization, involves a Mississippi law banning nearly all abortions over 15 weeks gestational age. Mississippi is asking the Supreme Court to overturn Roe v. Wade, and therefore overturn the constitutional right to abortion that…
In this video, KFF Associate Director for Women's Health Policy Laurie Sobel describes how a ruling overturning Roe could affect abortion access in the United States.
This issue brief explains why constitutional amendment ballot measures have become so popular with advocates on both sides of the abortion issue, reviews the current initiatives that are in progress and may appear in on state ballots the next general election, and outlines the processes states have available to them to use to place initiatives on the ballot.
Nearly a year after the Supreme Court overturned Roe v. Wade, this poll examines the public's views of abortion and the Supreme Court, and knowledge about mifepristone, a medication abortion drug that is the subject of another court case, the ACA's preventive services provision and HIV in the US.
This report, based on a nationally representative survey of office-based OBGYNs practicing in the United States, examines the provision of sexual and reproductive health care provided by OBGYNs before and after the Dobbs decision, comparing the experiences of OBGYNs practicing in states where abortion is fully banned, states with gestational restrictions, and states where abortion remains available under most circumstances.
© 2026 KFF
